Concepedia

John Messina

JM

34

Publications

3.1K

Citations

25

H-Index

2000

Active since

Affiliations

OptiNose (United States)(Current)

OptiNose (Norway)

University of Pennsylvania

Novartis (United States)

Mount Sinai Beth Israel

John Messina is an author at OptiNose (United States) specializing in pharmacology, medicine, and health sciences.

ORCID

Top concepts

Publications per year

2000–2024

34

Publications

34

Novel Gene Mutations in Patients With Left Ventricular Noncompaction or Barth Syndrome

Fukiko Ichida, Shinichi Tsubata, Karla R. Bowles et al. · Circulation · 2001 · 557 citations

A 52-Week Study of the Efficacy of Rivastigmine in Patients with Mild to Moderately Severe Alzheimer’s Disease

Martin R. Farlow, Ravi Anand, John Messina et al. · European Neurology · 2000 · 327 citations

A Randomized, Placebo-controlled Study of Fentanyl Buccal Tablet for Breakthrough Pain in Opioid-treated Patients With Cancer

Russell K. Portenoy, Donald R. Taylor, John Messina et al. · Clinical Journal of Pain · 2006 · 223 citations

An efficacy and safety analysis of Exelon<sup>®</sup> in Alzheimer’s disease patients with concurrent vascular risk factors

Vinod Kumar, R. Anand, John Messina et al. · European Journal of Neurology · 2000 · 161 citations

Brain metabolic and clinical effects of rivastigmine in Alzheimer's disease

Steven G. Potkin, Ravi Anand, Kirsten Fleming et al. · The International Journal of Neuropsychopharmacology · 2001 · 159 citations · Full text

Rows per page

1–5 of 34